Serum total cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7
|
0.400 |
GeneticVariation
|
disease |
UNIPROT |
A loss-of-function mutation in tryptophan hydroxylase 2 segregating with attention-deficit/hyperactivity disorder.
|
18347598 |
2008 |
Unipolar Depression
|
0.800 |
Biomarker
|
disease |
PSYGENET |
Although the majority of first-line antidepressants increase brain serotonin and rare polymorphisms in tryptophan hydroxlase-2 (Tph2), the rate-limiting enzyme in the brain serotonin synthesis pathway, have been identified in cohorts of subjects with major depressive disorder, the circuit level alterations that results from serotonergic hypofunction remain poorly understood.
|
23467366 |
2013 |
Unipolar Depression
|
0.800 |
Biomarker
|
disease |
PSYGENET |
Polymorphisms in the gene encoding the serotonin synthesis enzyme Tph2 have been identified in mental illnesses, including bipolar disorder, major depression, autism, schizophrenia, and ADHD.
|
24196946 |
2014 |
Unipolar Depression
|
0.800 |
Biomarker
|
disease |
PSYGENET |
Lack of association between TPH2 gene polymorphisms with major depressive disorder in multiethnic Malaysian population.
|
24376086 |
2015 |
Unipolar Depression
|
0.800 |
Biomarker
|
disease |
PSYGENET |
Tryptophan hydroxylase 2 gene is associated with cognition in late-onset depression in a Chinese Han population.
|
26057341 |
2015 |
Unipolar Depression
|
0.800 |
Biomarker
|
disease |
PSYGENET |
A rare mutation in tryptophan hydroxylase 2 (Tph2), the rate limiting enzyme for 5-HT synthesis, was identified in several patients with major depression, and knock-in mice expressing the analogous mutation (R439H Tph2 KI) show 80% reduction in 5-HT synthesis and tissue levels.
|
23336047 |
2013 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Furthermore, the TPH2(-/-) mouse may serve as a useful model in the search for new medications that have therapeutic targets for depression that are outside of the 5HT neuronal system.
|
25089765 |
2014 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
The results of our analysis indicated no significant differences in the frequencies of the single alleles and genotypes of two polymorphisms in TPH2 gene between LOD patients and normal controls.
|
26057341 |
2015 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Common polymorphisms involved in the tryptophan hydroxylase 1 (TPH1) and 2 (TPH2), serotonin transporter, monoamine oxidase A (MAOA) and brain-derived neurotrophic factor (BDNF) were investigated in a naturalistic inpatient study of the German research network on depression.
|
23063133 |
2013 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
We tested these mice along with C57BL/6 mice (Tph2C/C), congenic C57BL/6 mice homozygous for the Tph21473G-allele (Tph2G/G), and heterozygous Tph2-deficient mice (Tph2C/-) for anxiety- and depression-like behavior, and evaluated brain serotonin metabolism and 5-HT1AR signaling by high-performance liquid chromatography and quantitative autoradiography, respectively.
|
24863038 |
2014 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
We hypothesize that functional polymorphisms (TPH2: rs7305115, 5-HTTLPR and rs25531) within both genes contribute to the risk of depressive disorders after childhood abuse in adult life.
|
25214390 |
2014 |
Major Depressive Disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Accumulating evidences suggest that Tryptophan hydroxylase 2 (TPH2) gene is associated with major depressive disorder (MDD) and cognitive function.
|
26057341 |
2015 |
Major Depressive Disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
A rare mutation in tryptophan hydroxylase 2 (Tph2), the rate limiting enzyme for 5-HT synthesis, was identified in several patients with major depression, and knock-in mice expressing the analogous mutation (R439H Tph2 KI) show 80% reduction in 5-HT synthesis and tissue levels.
|
23336047 |
2013 |
Major Depressive Disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Polymorphisms in the gene encoding the serotonin synthesis enzyme Tph2 have been identified in mental illnesses, including bipolar disorder, major depression, autism, schizophrenia, and ADHD.
|
24196946 |
2014 |
Major Depressive Disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Single locus analysis in pooled and ethnically stratified subjects revealed no association between each of the three variants of the TPH2 gene with susceptibility to MDD.
|
24376086 |
2015 |
Major Depressive Disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Although the majority of first-line antidepressants increase brain serotonin and rare polymorphisms in tryptophan hydroxlase-2 (Tph2), the rate-limiting enzyme in the brain serotonin synthesis pathway, have been identified in cohorts of subjects with major depressive disorder, the circuit level alterations that results from serotonergic hypofunction remain poorly understood.
|
23467366 |
2013 |
Bipolar Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
The aim of this study is to investigate a possible association between TPH2 gene polymorphisms and the PD comorbidity susceptibility.Our sample consisted of 515 patients; 274 patients with BD (subtypes I and II), including 45 patients with lifetime panic disorder comorbidity and 241 controls.
|
21085052 |
2011 |
Bipolar Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Our results suggest that TPH2 variants neither have a major role in MD, BD and schizophrenia nor in response to treatments.
|
21396719 |
2011 |
Bipolar Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
We analyzed 62 genotyped variants within the selected genes (BDNF, NTRK2, SLC6A4, TPH2, P2RX7, DAOA, COMT, DISC1, and MAOA) against the presence of mood disorder, and in post-hoc analyses, specifically against bipolar disorder or major depressive disorder.
|
21438144 |
2011 |
Bipolar Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Our results indicate that in the Han Chinese population TPH2 may be a potential susceptibility gene for bipolar disorder.
|
25152196 |
2015 |
Bipolar Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Polymorphisms in the gene encoding the serotonin synthesis enzyme Tph2 have been identified in mental illnesses, including bipolar disorder, major depression, autism, schizophrenia, and ADHD.
|
24196946 |
2014 |
Mental Depression
|
0.400 |
Biomarker
|
disease |
PSYGENET |
The results of our analysis indicated no significant differences in the frequencies of the single alleles and genotypes of two polymorphisms in TPH2 gene between LOD patients and normal controls.
|
26057341 |
2015 |
Mental Depression
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Common polymorphisms involved in the tryptophan hydroxylase 1 (TPH1) and 2 (TPH2), serotonin transporter, monoamine oxidase A (MAOA) and brain-derived neurotrophic factor (BDNF) were investigated in a naturalistic inpatient study of the German research network on depression.
|
23063133 |
2013 |
Mental Depression
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Furthermore, the TPH2(-/-) mouse may serve as a useful model in the search for new medications that have therapeutic targets for depression that are outside of the 5HT neuronal system.
|
25089765 |
2014 |